EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 3
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

First medicine approved in the U.S. specifically for the treatment of aTTP, a rare blood-clotting disorderCablivi is the first U.S. approval for Sanofi's new rare bl...
14 February 2019 Europe | news | Regional News
Continue Reading →
news

From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Plymouth Meetin...
14 February 2019 news | North America | Regional News
Continue Reading →
Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...
14 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...
14 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
Europe

4 of the Top 7 Global CROs Have Selected Veeva Vault eTMF as Their Enterprise Standard

BARCELONA, Spain — 13 February 2019 — Veeva Systems (NYSE:VEEV) today announced four of the world’s top seven largest CROs are standardizing on V...
14 February 2019 Europe | news | Regional News
Continue Reading →
Europe

SGS to Conduct its First Malaria Human Challenge Trial in Belgium

Antwerp, Belgium, February 12, 2019 SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today announced that it will commence ...
14 February 2019 Europe | news | Regional News
Continue Reading →
Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...
12 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
news

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies.

Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegener...
7 February 2019 news | North America | Regional News
Continue Reading →
news

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthroug...
7 February 2019 news | North America | Regional News
Continue Reading →
news

FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exc...
7 February 2019 news | North America | Regional News
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte